Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nair Y Maeda

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Increased tyrosine phosphorylation of platelet proteins including pp125(FAK) suggests endogenous activation and aggregation in pulmonary hypertensionNair Y Maeda, Sergio P Bydlowski, Antonio A Lopes
Cardiology in the Young|December 21, 2007
Altered endothelial function following the Fontan procedureMaria A Binotto, Nair Y Maeda, Antonio A Lopes
Cardiology in the Young|April 16, 2005
Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operationMaria A Binotto, Nair Y Maeda, Antonio A Lopes
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2004
Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertensionLúcia H Caramuru, Nair Y Maeda, Sérgio P Bydlowski, et al.
Cardiology in the Young|September 17, 2005
Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndromeRosangela de P S Soares, Nair Y Maeda, Sérgio P Bydlowski, et al.
Congenital Heart Disease|October 22, 2018
Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart diseaseMariana M Clavé, Nair Y Maeda, Ana M Thomaz, et al.
Chemistry and Physics of Lipids|July 1, 2017
Outside-in, inside-out: Proteomic analysis of endothelial stress mediated by 7-ketocholesterolLívia Rosa-Fernandes, Luciana M F Maselli, Nair Y Maeda, et al.
Pulmonary Circulation|July 14, 2017
Factors influencing outcomes in patients with Eisenmenger syndrome: a nine-year follow-up studyMariana M Clavé, Nair Y Maeda, Claudia R P Castro, et al.
Thrombosis Research|May 19, 2009
Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertensionNair Y Maeda, João H Carvalho, Andréia H Otake, et al.
Mediators of Inflammation|March 19, 2019
Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac ShuntsNair Y Maeda, Vera D Aiello, Paulo C Santos, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Increased tyrosine phosphorylation of platelet proteins including pp125(FAK) suggests endogenous activation and aggregation in pulmonary hypertensionNair Y Maeda, Sergio P Bydlowski, Antonio A Lopes
Cardiology in the Young|December 21, 2007
Altered endothelial function following the Fontan procedureMaria A Binotto, Nair Y Maeda, Antonio A Lopes
Cardiology in the Young|April 16, 2005
Evidence of endothelial dysfunction in patients with functionally univentricular physiology before completion of the Fontan operationMaria A Binotto, Nair Y Maeda, Antonio A Lopes
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2004
Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertensionLúcia H Caramuru, Nair Y Maeda, Sérgio P Bydlowski, et al.
Cardiology in the Young|September 17, 2005
Markers of endothelial dysfunction and severity of hypoxaemia in the Eisenmenger syndromeRosangela de P S Soares, Nair Y Maeda, Sérgio P Bydlowski, et al.
Congenital Heart Disease|October 22, 2018
Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart diseaseMariana M Clavé, Nair Y Maeda, Ana M Thomaz, et al.
Chemistry and Physics of Lipids|July 1, 2017
Outside-in, inside-out: Proteomic analysis of endothelial stress mediated by 7-ketocholesterolLívia Rosa-Fernandes, Luciana M F Maselli, Nair Y Maeda, et al.
Pulmonary Circulation|July 14, 2017
Factors influencing outcomes in patients with Eisenmenger syndrome: a nine-year follow-up studyMariana M Clavé, Nair Y Maeda, Claudia R P Castro, et al.
Thrombosis Research|May 19, 2009
Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertensionNair Y Maeda, João H Carvalho, Andréia H Otake, et al.
Mediators of Inflammation|March 19, 2019
Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac ShuntsNair Y Maeda, Vera D Aiello, Paulo C Santos, et al.
Pageof 2